Key result
Postoperative SCAI shock stage after 48 hours strongly predicts in-hospital mortality up to 85%.
Why the study?
Does the SCAI shock stage classification predict in-hospital mortality in cardiac surgery patients postoperatively?
Cohort (n=9,293)
No
Does the SCAI shock stage classification predict in-hospital mortality in cardiac surgery patients postoperatively?
p-value: p=<0.001
The SCAI shock stage classification has limited prognostic value for in-hospital mortality within the first 48 hours after cardiac surgery (except for stage E), but its predictive accuracy improves significantly after 48 hours.
Background The Society for Cardiovascular Angiography and Interventions (SCAI) classification is a risk stratification tool to define the severity of cardiogenic shock [1,2]. Earlier studies conducted in predominantly critically ill cardiac non-surgical patients have reported in-hospital mortality rates for each SCAI shock stage as follows: A, 1-5%; B, 0-34%; C, 11-54%; D, 24-68%; and E, 42-77% [3]. However, it is unknown whether the SCAI shock classification confers prognostic value in patients after cardiac surgery. Purpose To assess whether the SCAI shock stage classification is a prognostic tool for cardiac surgery patients postoperatively. Methods A single-center retrospective analysis was conducted in 9.293 cardiac surgery patients operated between 2015 and 2024. All patients were categorized into SCAI shock stages A through E, at 0-24 hours, 24-48 hours and up to 144-168 hours postoperatively. Absolute, maximum and changes in SCAI shock stage were tested. The relationship between SCAI shock stages and in-hospital mortality was evaluated. Results Distribution of patients across SCAI shock stages A to E during the first 0-24 hours postoperative was 42%, 18%, 5%, 33%, and 2%, with corresponding in-hospital mortality rates of 0.3%, 1%, 4%, 4%, and 35%(p<0.001; p<0.001). At 48-72 hours postoperatively the distribution and associated in-hospital mortality of patients differs, as seen in Figure 1. At 48 hours postoperatively, 91% of patients were classified as SCAI shock stage A or B(p<0.001). Only SCAI shock stage E was associated with high in-hospital mortality from baseline onwards. Among patients in non-resolving shock (i.e. those who did not improve, remained in shock or died) and resolving shock (i.e. those who improved or remained in no shock) between 0-24 hours and 48-72 hours postoperatively, the difference in distribution is seen at Figure 2. The in-hospital mortality rates associated with non-resolving shock after 48 hours were markedly higher — 13%, 19%, 42%, 22%, and 85% — compared to resolving shock, with mortality rates of 0.2%, 0.7%, 1.5%, 1.5%, and 15%(p<0.001). Kaplan-Meier analysis, corrected for Benjamini-Hochberg, showed no stepwise increase in in-hospital mortality across SCAI shock stages within 48 hours, but this became significant after 48 hours, except between stage A and B(p=0.114). However, when stages A and B were combined, mortality was significantly lower compared to stage C(p<0.001). Conclusion(s) The SCAI shock stage classification is not related to in-hospital mortality when evaluated during the first 48 postoperative hours except for patients in stage E for whom it is a strong indicator of high in-hospital mortality. After 48 hours the prognostic value of the SCAI shock stage classification improves for the different SCAI shock stages as it aligns more closely with the in-hospital mortality. This implies that in the first 48 postoperative hours other factors play a crucial role in determining patient outcomes.Shock stage distribution and mortality Non-resolving and resolving shock
No takes yet. Share an insight, caveat, or question.
Baldan et al. (2025) conducted a cohort in cardiogenic shock after cardiac surgery (n=9,293). SCAI shock stage classification vs. Lower SCAI shock stages or resolving shock was evaluated on in-hospital mortality (p=<0.001). SCAI shock stage classification after 48 hours post-cardiac surgery strongly predicted in-hospital mortality, with rates for non-resolving shock ranging from 13% to 85% across stages A-E (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: